Compare SIGA & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIGA | PFL |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.0M | 371.7M |
| IPO Year | 2016 | 2003 |
| Metric | SIGA | PFL |
|---|---|---|
| Price | $5.17 | $8.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 751.2K | 274.6K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | 11.21% | ★ 11.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $224.81 | N/A |
| P/E Ratio | $16.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.81 | $7.11 |
| 52 Week High | $9.62 | $8.70 |
| Indicator | SIGA | PFL |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 49.96 |
| Support Level | $4.81 | N/A |
| Resistance Level | $6.98 | $8.49 |
| Average True Range (ATR) | 0.23 | 0.13 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 50.00 | 83.96 |
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. The company seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.